63
Buy Biktarvy (Bictegravir/ emtricitabine/ tenofovir alafenamide) Online
Biktarvy (Bictegravir/ emtricitabine/ tenofovir alafenamide) for HIV Treatment Medication Online Now.
For more information about the medication and ordering process, please contact us at pulseliving@pulse-clinic.com or chat with us on your preferred platform.
+66-84-226-2569
@pulserx
PulseClinic
Studies presented at ID WEEK 2018 in San Francisco show that the latest once-daily, all-in-one HIV pills help maintain an undetectable viral load for over two years. Two phase 3 clinical trials found that most people taking either the Bictegravir-based pill or the doravirine-based DELSTRIGO pill as their first treatment had an undetectable viral load after 96 weeks.
Medication | Price |
![]() | BIKTARVY 5590 THB |
David Wohl from the University of North Carolina presented findings comparing Biktarvy and Triumeq in 629 HIV treatment-naive participants. The primary results, shared at IAS 2017, showed that after 96 weeks, 87.9% of Biktarvy users and 89.8% of Triumeq users had undetectable viral loads, demonstrating Biktarvy's non-inferiority. Both regimens were equally effective, with rare virological failure (0.6% for Biktarvy, 2.2% for Triumeq). Treatment was generally safe, with fewer side effects in the Biktarvy group (28% vs. 40%). Kidney and bone effects were minimal, and cholesterol increased slightly in both groups. Biktarvy was shown to have long-term safety, efficacy, and resistance protection.
BIKTARVY tablets contain the following medications:
Bictegravir is part of a class of antiretroviral drugs called integrase strand transfer inhibitors (INSTIs).
Emtricitabine and tenofovir alafenamide belong to the antiviral medication groups known as nucleoside reverse transcriptase inhibitors (NRTIs) and nucleotide reverse transcriptase inhibitors (NtRTIs), respectively.
These medications are combined into a single tablet to help manage Human Immunodeficiency Virus 1 (HIV-1) infection in adults and children weighing at least 25 kg.
BIKTARVY lowers HIV levels in the blood (viral load) and may help increase T cells (CD4+ cells), boosting the immune system. By reducing HIV, it lowers the risk of complications like death or infections that happen when the immune system is weak.
HIV destroys CD4+ T cells, which are crucial for fighting infections, and losing too many can lead to AIDS.
BIKTARVY is for people without HIV strains resistant to it.
Emtricitabine and tenofovir alafenamide are also in DESCOVY, GENVOYA, and ODEFSEY, while VEMLIDY contains tenofovir alafenamide.
BIKTARVY is approved for treating HIV-1 infection in adults and children weighing at least 25 kg.
The safety and efficacy of BIKTARVY in children and adolescents under 18 have not yet been established.
BIKTARVY does not cure HIV infection, AIDS or HBV infection.
The long-term effects of BIKTARVY are unknown. People on BIKTARVY or other HIV medications may still be at risk for infections or conditions linked to HIV. Opportunistic infections, like pneumonia and herpes, can happen when the immune system is weakened.
BIKTARVY is available only with a prescription from a doctor who specializes in HIV treatment.
To continue using BIKTARVY, you must stay under the care of an HIV specialist.
BIKTARVY effectively lowers the risk of transmitting HIV, but a small risk remains.
Talk to your doctor about precautions to prevent spreading HIV.
For your health and others', always use condoms or another barrier method, and never share needles.
Together with your doctor, you need to decide whether BIKTARVY is right for you.
Do not take BIKTARVY if you are allergic to:
The ingredients of BIKTARVY are listed in the product description section of this leaflet.
Do not take BIKTARVY if you are already taking any other medicines that contain the same active ingredients.
Do not take BIKTARVY if you are taking other medicines that contain:
Do not take BIKTARVY to treat your HIV infection if you are also taking dofetilide to treat heart conditions.
Do not take BIKTARVY to treat your HIV infection if you are also taking rifampicin to treat infections.
Do not take BIKTARVY to treat your HIV infection if you are also taking adefovir dipivoxil to treat your hepatitis B virus (HBV) infection.
Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes.
Tell your doctor if you have, or have had, any of the following medical conditions:
Tell your doctor if you are pregnant, or likely to become pregnant during your course of medication. We do not know if BIKTARVY can harm your unborn child. You and your doctor will need to decide if BIKTARVY is right for you.
Tell your doctor if you are breastfeeding, or likely to breastfeed during your course of medication. You should not breastfeed if you are HIV-positive because of the chance of passing the HIV virus to your baby. At least one of the active substances in this medicine (emtricitabine) has been found in breast milk at low concentrations. Talk with your doctor about the best way to feed your baby.
Inform your doctor or pharmacist if you are taking any other medications, including those purchased without a prescription from your pharmacy, supermarket, or health food store.
Some medications can interact with BIKTARVY. These include:
This list is not exhaustive. Other medications may also affect how well BIKTARVY works, or BIKTARVY may impact the effectiveness of other medications. You may need adjusted doses or different medications.
Therefore, it's crucial to inform your doctor or pharmacist about all the medications, herbal supplements, or vitamins you are taking.
Keep track of your medications. Maintain a list and share it with your doctor or pharmacist whenever you start a new medication.
Do not start any new medicines while you are taking BIKTARVY without first talking with your doctor or pharmacist.
Biktarvy (Bictegravir/ emtricitabine/ tenofovir alafenamide) for HIV Treatment Medication Online Now.
For more information about the medication and ordering process, please contact us at pulseliving@pulse-clinic.com or chat with us on your preferred platform.
+66-84-226-2569
@pulserx
PulseClinic
I have my prescription and I want to order now, TAKE ME THERE !
Take the exact amount of BIKTARVY your doctor has prescribed for you.
Never change the dose on your own.
Do not stop this medicine unless your healthcare provider tells you to stop.
The usual dose is one BIKTARVY tablet orally, once daily.
Take BIKTARVY with or without food.
Do not chew, crush or split the tablet.
If you are taking an antacid (such as aluminium/magnesium hydroxide), a mineral supplement or vitamin (containing calcium or iron), ulcer-healing medication (such as sucralfate), or a buffered medication (containing calcium carbonate), take BIKTARVY at least 2 hours before taking these medications.
Alternatively, you can take the medication and BIKTARVY together with food.
Do not miss a dose of BIKTARVY.
If you forget to take BIKTARVY, take your missed dose right away unless it is almost time for your next dose.
Do not take a double dose to make up for a forgotten dose. Continue with your regular dosing schedule.
When your BIKTARVY supply starts to run low, get more from your doctor or pharmacy. This is very important because the amount of virus in your blood may increase if the medicine is stopped for even a short time. The virus may develop resistance to BIKTARVY and become harder to treat.
Immediately telephone your doctor or Poisons Information Centre: 131126 (Australia) and 0800 764 766 (New Zealand) or go to the Accident and Emergency department at your nearest hospital if you think you or anyone else may have taken too many BIKTARVY tablets. Do this even if there are no signs of discomfort or poisoning. This may need urgent medical attention.
Do not breastfeed. See “Before you start to take it”
Avoid doing things that can spread HIV infection.
Always practice safer sex by using a latex or polyurethane condom or other barrier to reduce the chance of sexual contact with semen, vaginal secretions, or blood.
Do not take BIKTARVY after the expiry or “use by” date (EXP) printed on the bottle. If you take it after the expiry date has passed, it may not work as well.
Do not take BIKTARVY if the packaging is torn or shows signs of tampering.
Be careful driving or operating machinery until you know how BIKTARVY affects you. If you are dizzy, have trouble concentrating, or are drowsy, avoid activities that may be dangerous, such as driving or operating machinery.
Like all medicines, BIKTARVY can have side effects, although not everybody gets them. Some may be serious and need medical attention.
Check with your doctor as soon as possible if you have any problems while taking BIKTARVY, even if you do not think the problems are connected with the medicine or are not listed in this leaflet.
Hepatic Flares
If you have both HIV infection and HBV infection you should not stop your BIKTARVY treatment without first discussing this with your doctor. Your HBV may get worse (flare-up) if you stop taking BIKTARVY. A “flare-up” or “hepatic flare” is when your HBV infection suddenly returns in a worse way than before. You may require medical exams and blood tests for several months after stopping treatment.
Signs and symptoms of inflammation
In some patients with advanced HIV infection (AIDS), signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. It is believed that these symptoms are due to an improvement in the body’s immune response, which lets the body fight infections that may have been present with no obvious symptoms. If you notice any symptoms of infection, please tell your doctor immediately.
Some people are allergic to medicines. If you have any of the following symptoms soon after taking your medicine, DO NOT TAKE ANY MORE BIKTARVY and tell your doctor IMMEDIATELY or go to the accident and emergency department at your nearest hospital:
These are very serious effects. If you have them, you may have a serious allergic reaction. You may need urgent medical attention or hospitalisation. Hypersensitivity reactions are very rare.
The most common side effects of BIKTARVY are diarrhoea and headache.
Other side effects include:
Talk to your doctor or pharmacist if you don’t understand anything in this list.
This is not a complete list of side effects possible with BIKTARVY.
Ask your doctor or pharmacist for a more complete list of side effects of BIKTARVY and all the medicines you will take.
Keep BIKTARVY tablets where children cannot reach them. A locked cupboard at least one-and-a-half metres above the ground is a good place to store them.
Keep BIKTARVY tablets in a cool, dry place where it stays below 30 °C.
Do not store BIKTARVY or any other medicine in a bathroom or near a sink.
Do not leave BIKTARVY in the car or on a window sill. Heat and dampness can destroy some medicines.
Keep your BIKTARVY tablets in the bottle with the cap tightly closed until you take them. If you take BIKTARVY tablets out of their pack they may not keep well.
The 50/200/25 mg BIKTARVY tablets are capsule-shaped, purplish-brown in color and film-coated.
Each tablet is debossed with “GSI” on one side and the number “9883” on the other side.
BIKTARVY tablets are supplied in bottles containing 30 tablets.
Each BIKTARVY tablet contains the active ingredients:
Each BIKTARVY tablet also contains the following inactive ingredients:
Film-coating
Chat with PULSE CLINIC ONLINE Department